Skip to content

Medmarc Insurance

Medmarc Blog (blog.medmarc.com)

FDA Appoints New Director for Center for Devices

November 12, 2024

The FDA has appointed a new director for the Center for Devices and Radiological Health (CDRH) to replace Jeff Shuren, who has been at the helm of CDRH since 2009. Michelle Tarver has taken over as...

Mammography False Positives Endanger Screening Compliance

October 31, 2024

A new study published recently in the Annals of Internal Medicine disclosed an association between false positive results on mammography screening exams and a reluctance to return for screening....

CMS Issues Final Policy For Breakthrough Device Coverage

August 30, 2024

The Centers for Medicare & Medicaid Services has delivered its final policy for the Transitional Coverage for Emerging Technologies (TCET) program, which incorporates existing coverage mechanisms....

Supreme Court Ruling Ends Courts’ Deference under Chevron

July 31, 2024

The Supreme Court of the United States has overturned a landmark legal doctrine of judicial deference to federal government agencies during litigation in federal courts. The 6-3 decision addresses...

FDA Final Rule for LDTs Offers Four-Year Phase-In

June 13, 2024

The FDA’s final rule for laboratory-developed tests (LDTs) imposes a large compliance burden on clinical laboratory operations, a fact which has sparked renewed interest in legislation. However, the...

Congress Reconsiders Expanding Telehealth Services for Diabetes Prevention

June 12, 2024

The House of Representatives and the Senate have both reintroduced legislation that would expand Medicare telehealth services for patients at risk for developing diabetes. The PREVENT DIABETES Act...

FDA’s Posts Final Guidance for Remanufacturing

May 14, 2024

The FDA has issued a final guidance for servicing and remanufacturing services for medical devices, which will end the agency’s enforcement discretion for remanufacturing activities. Manufacturers...

GAO Report Highlights FDA Staff Shortages for BiMo Inspections

April 24, 2024

The U.S. Government Accountability Office stated in a recent report that the FDA’s ability to fill openings in its Bioresearch Monitoring (BiMo) workforce has been impeded by several factors, such...

White House Announces Women’s Health Research Program

December 27, 2023

The White House has announced a program titled the Initiative on Women’s Health Research, which among other things will amplify ongoing programs at the FDA designed to improve health outcomes for...

FDA Guidance Promises Closer Scrutiny of Medical Device Cybersecurity

November 29, 2023

The FDA’s most recent final guidance for medical device cybersecurity represents a significant shift in the agency’s perspectives regarding cybersecurity, which is part of a broader emphasis on...